3B BlackBio Dx board to review Q2 and H1 financial results

3B BlackBio Dx Ltd. announced that its board of directors will convene on Thursday, November 13, 2025, at 3:00 p.m. The primary agenda for the meeting, to be held at the company's registered office, is to consider and approve the unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025.

In accordance with SEBI regulations, the trading window for the company's equity shares closed on Wednesday, October 1, 2025. This window will remain closed for 48 hours following the announcement of the financial results on November 13, 2025, to prevent insider trading. The announcement was made by whole time director Nikhil Kuber Dubey and digitally signed on November 6, 2025.